TBPH
Theravance Biopharma Inc

1,026
Mkt Cap
$1.01B
Volume
266,488.00
52W High
$20.79
52W Low
$7.90
PE Ratio
35.57
TBPH Fundamentals
Price
$20.01
Prev Close
$20.11
Open
$20.06
50D MA
$18.34
Beta
0.54
Avg. Volume
487,261.77
EPS (Annual)
-$1.16
P/B
4.36
Rev/Employee
$663,721.65
Loading...
Loading...
News
all
press releases
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Analysts
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Get Free Report) have earned an average rating of "Buy" from the seven research firms that are covering the firm, MarketBeat Ratings reports. Two...
MarketBeat·5d ago
News Placeholder
Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·14d ago
News Placeholder
mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session
read more...
Benzinga·15d ago
News Placeholder
Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving Average - What's Next?
Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving Average - Time to Sell...
MarketBeat·17d ago
News Placeholder
Theravance Biopharma (NASDAQ:TBPH) Lowered to Buy Rating by Wall Street Zen
Wall Street Zen cut Theravance Biopharma from a "strong-buy" rating to a "buy" rating in a report on Saturday...
MarketBeat·17d ago
News Placeholder
Inspire Investing LLC Purchases New Position in Theravance Biopharma, Inc. $TBPH
Inspire Investing LLC purchased a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·25d ago
News Placeholder
Here's Why Theravance Biopharma (TBPH) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·27d ago
News Placeholder
Wall Street Analysts Believe Theravance Bio (TBPH) Could Rally 42.15%: Here's is How to Trade
The mean of analysts' price targets for Theravance Bio (TBPH) points to a 42.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·29d ago
News Placeholder
Assenagon Asset Management S.A. Boosts Position in Theravance Biopharma, Inc. $TBPH
Assenagon Asset Management S.A. boosted its position in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) by 1,629.4% during the 3rd quarter, according to its most recent Form 13F filing with...
MarketBeat·29d ago
<
1
2
...
>

Latest TBPH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.